Viramune®
nevirapine
About Viramune®
For the combination therapy of HIV-1 infection and (in several countries) for the prevention of mother-to-child transmission of HIV-1 in pregnant women who are not taking antiretroviral therapy at time of labour.
Prolonged release tablets for once-daily dosing within combination therapy.
Professional Area
You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.
Product Key Facts
Indications
HIV/AIDS
Brand Names
Viramune® Viramune XR®
Active ingredients
nevirapine